INTRODUCTION
Cell proliferation is a process fundamental to growth, development, adaptation to disease and neoplasia. Assessing proliferation is often a pivotal investigation in biomedical science, and a range of techniques have evolved to quantify the process, both directly and indirectly, in vitro and in vivo. The purpose of this paper is to review the methods available. Reflecting the interests of our laboratory, illustrative examples will be drawn from studies on the proliferation of the liver and gastrointestinal tract, but the principles are obviously of general application.
Cell cycle
The concept of the cell cycle is central to cell proliferation. Howard and Pelc [ 11 formulated the concept after their autoradiographic studies on bean roots showed a period of intense DNA synthesis. Recognition of this synthetic (S) phase combined with the readily recognizable mitotic (M) phase as two landmarks separated by two gaps led to the model of the cell cycle, a series of discrete phases resulting in two daughter cells that may repeat the cycle. As illustrated in Fig. 1 , M phase is followed by G1, the post-mitotic gap, and S phase is followed by the post-synthetic gap G2, which is then followed by a further M phase in progressively proliferating tissue. Cells not actively proliferating can temporarily occupy a fifth phase (GO) after M phase, but with appropriate stimuli may be recruited to reenter the cycle. Other cells permanently exit the cell cycle, often associated with terminal differentiation and loss of proliferative competence. In many tissues these mature cells migrate away from proliferative areas, for example the maturing enterocyte from the crypt region to the tip of the villus, or the passage of erythrocytes out of the bone marrow into the circulation.
Most adult tissues comprise a mixture of cycling cells, quiescent cells and terminally differentiated cells. Most assessments of the proliferative characteristics of a tissue describe the proportion of cells that are proliferating during a short time-period, generally by recognition and quantification of the number of cells in S or M phase. This may be all that is required for experimental purposes, but is incomplete, particularly if there is more than one cell type present or if the proliferation is regional. Another pitfall in merely quantifying cells in S or M phase is that the duration of these stages may vary with proliferative rate. A full description involves not only the proportion of cells in S or M phase, but the rate at which cells enter and leave the cell cycle, and their distribution within the tissue. This paper will review the principles and techniques for recognizing and quantifying S phase, M phase and other cell-cycle-related phenomena, as well as other quantitative approaches to proliferation, and will relate these to applications in vivo and in organ and tissue culture.
CELL-CY CLE-RELATED METHODS

Mphase methods
Mitosis is the only cell-cycle phase that can be identified in conventional stained tissues, by the characteristic mitotic figures as chromatin condenses and divides. Mitotic counts provide a simple reflection of the proportion of proliferating cells cheaply and conveniently, and are easily performed prospectively or retrospectively on routine histological sections. Technical factors (section thickness, staining and fixation) need to be controlled as these affect mitotic counts and lead to lack of reproducibility [2] . Another criticism centres on the potential instability of mitotic figures. Delays in tissue fixation were noted to result in apparently fewer mitotic figures, originally attributed to completion of mito- sis after explantation [4, 51. It seems more likely that the apparent decline in mitotic counts with delayed fixatipn reflects distortion of mitotic figures, rendering them less recognizable, as indices of proliferation derived from enumerating cells in S phase remain constant [ 6 ] . Delayed fixation may also result in involuted pyknotic nuclei which may be interpreted as mitotic figures. Irrespective of fixation time, hyperchromatic and deformed nuclei can be confused with mitotic figures (reviewed by Baak [2] ). Observer variation may occur [7, 81 , as trained observers can identify mitotic figures from early prophase to late telophase, whilst novices recognize a more restricted range. There are some image recognition software programs to try and reduce subjectivity, but these are not in general use.
There are two main conventions for enumerating M phases:
Mitotic counts. The traditional approach (e.g. the number of mitotic counts per ten high-power fields) is valueless for comparing between studies, due to six-fold variations in the 'high-power field area' [9] . Counts per area are also of little use in inhomogeneous tissue such as the small intestinal mucosa, where cell division is concentrated in crypts. Even in apparently homogeneous tissue, such as solid tumours, there may be regional differences reflecting variations in nutrition and vascularity [lo] . Mitotic counts may, however, be valuable if they can be enumerated in a compartment, for example microdissected gastric glands or small intestinal crypts (Fig. 2) [ll] . Under these circumstances the information is of real biological value.
Mitotic indices. Here, the fraction of the counted nuclei in mitosis is calculated. One problem is that proliferative rates may differ between tissues with apparently identical mitotic indices, due to varying rates of passage through the cell cycle. If related to cell morphology, this index does, however, allow the proportion of cells of a given type in inhomogeneous tissue to be counted.
As an alternative to enumerating mitoses at a single time point, the rate at which cells enter mitosis can be quantified. This approach addresses the fact that the duration of metaphase in a given tissue may not be constant, so that under different 
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circumstances the same mitotic count may be found, reflecting either a small number of cells cycling slowly or a larger number cycling quickly. The rate of entry into mitosis can be determined by the 'metaphase arrest technique', essentially serial mitotic figure counting [12] . The technique uses agents such as vincristine to prevent dividing cells from completing the cell cycle. After priming with a blocking agent multiple samples are taken at different time-points, either by serial biopsy in uivo, or by serial sampling if blocking is performed in cultures ex uiuo. By counting the accumulation of the metaphases arrested at each interval, an estimate of the cohort of cells entering mitosis is made. When plotted against time, the slope of the line represents the mitotic rate, or birth rate, of the population. This is a complicated method, requiring a systemic [13] or local [14] blocking agent and serial biopsies. Doses of the blocking agent are critical and need to be optimized in preliminary experiments [12] . The problems outlined for mitosis counting are compounded by the difficulties encountered in recognizing arrested mitotic figures. Use of this method in humans in uivo requires the systemic administration of agents such as vincristine; its use in the past has been controversial and it is likely to be less acceptable currently.
Sphase methods
In contrast to M-phase methods, which rely on morphological recognition of the phase of the cell cycle, the DNA synthetic phase can be assessed by either morphological or biochemical techniques. It is thus more versatile and more objectively quantifiable. Techniques rely on recognizing the process of DNA synthesis by the assimilation of radiolabelled, or otherwise modified, nucleotides into new DNA.
Radiolabelled molecules.
[ 3H]Thymidine is a commonly used radionucleotide, reflecting in part its specificity as a DNA precursor. Unlike alternative DNA precursors, such as orotic acid, thymidine is not incorporated into RNA. In addition, there is a so-called salvage pathway by which cells are able to take up free thymidine from the medium, which occurs in competition with endogenously synthesized thymidine (Fig. 3) . Intracellular thymidine is mainly in the form of thymidine triphosphate, which is largely derived by synthesis de nouo from endogenous deoxyuridine monophosphate (dUMP). Thymidine kinase is the major enzyme regulating the cellular uptake of exogenous thymidine [16] and is susceptible to inhibition by intracellular thymidine triphosphate. The intracellular thymidine pool is maintained in careful equilibrium and proliferation can be inhibited by excess thymidine. Altering these conditions can optimize experiments performed in vitro. Exogenous thymidine uptake can be facilitated with hyperbaric oxygen, or by inhibiting the endogenous formation of thymidine triphosphate from dUMP by blockade of thymidylate synthetase, for example, by 5-fluoroxyuridine and 2'-deoxy-5-fluoroxyuridine [ 171.
There are a number of potential artifacts in relating thymidine uptake to DNA synthesis [ 151.
Reparative DNA synthesis. Although most DNA synthesis is during cell replication, not all DNA synthesis detected by [3H] thymidine incorporation reflects proliferation. DNA is constantly being restored to maintain its integrity in the face of damage. Indeed, such damage can be caused by the presence of radioactive thymidine, since emissions of the isotope may introduce chromosomal breaks and abberations. The contribution of replicative DNA synthesis to the total can be established experimentally, in vitro, by hydroxyurea blockade [ 181. This inhibits ribonucleotide reductase, which catalyses the reduction of nucleoside diphosphates to deoxynucleoside triphosphates.
Non-specific 3H-labelling of proteins. Incorporation of 3H into cellular macromolecules other than DNA, such as RNA and lipids [19, 201 , can occur when 3H-labelled breakdown products of thymidine are generated either by cellular metabolism or by spontaneous decomposition of stored thymidine. 3H-Labelled products arise most frequently after demethylation of the labelled pyrimidine ring and are more frequent in long labelling studies. The potential for this artifact can be reduced by using thymidine labelled at the 2-position. Non-covalent interactions between intact thymidine and cellular proteins also occur.
Re-utilization of thymidine. Artifacts may also occur in tissues that are rapidly turning over, such as bone marrow, where there is evidence of reutilization in neighbouring cells of thymidine liberated from the DNA of the dead cells [21] .
Other artifacts. Mycoplasma, which may give rise to inapparent infection in tissue culture, can metabolize thymidine, deprive the target cells and render incorporation spuriously low.
Techniques
Techniques for assessing thymidine uptake are either morphological, depending on autoradiography, or physical, depending on P-counting [22] . Virtually all techniques depend on tissue sampling, although an innovative approach using positron emission tomography (PET) to detect thymidine uptake in the regenerating liver has been explored in a study using [2-"C]thymidine [23] . This showed that uptake and retention of thymidine assessed by PET was increased in regenerating rat liver compared with controls.
Autoradiography. Autoradiography on tissue sections [17] or monolayer cultures (Fig. 4) visua- lizes isotope incorporation into DNA in S phase by the presence of dense silver grains overlying nuclei in active DNA synthesis. An immediate advantage is in investigating tissues which contain cells of varying lineages, since the nature of the cells dividing can in principle be readily recognized, and proliferative indices for different cell types defined. The use of this morphological approach introduces the same limitations of observer bias, counting errors, standardization and reproducibility as discussed for mitotic counting, but S-phase recognition has advantages. The S phase of the cell cycle can be up to 10 times the duration of M phase, so that a larger proportion of the cell population is involved, resulting in a greater ease of obtaining statistically adequate samples [24] . Pyknotic or fragmented nuclei do not cause confusion. Although the highest density of silver grains occurs in association with nuclei undergoing active DNA synthesis in S phase, there is also a 'background' count of grains over interphase nuclei. The reasons for this include light, environmental radiation, mechanical stress, factors inherent in the emulsion and, possibly, 3H-labelling of proteins. Criteria have to be developed to discriminate positive nuclei from background. Plotting the interphase grain distribution can be used to justify a particular grain count threshold [25] , but many workers use arbitrary thresholds of either five or eight grains/nucleus. Frustratingly, the silver grains in the emulsion lie in a different plane from the emitting nuclei, making it more difficult to obtain good illustrative material. The detection of S-phase cells by thymidine incorporation can be applied in various ways. 'Flash' labelling refers to a labelling period shorter than the S-phase duration and only members of the population which are instantaneously in the synthetic phase are labelled. In continuous labelling, the thymidine is available for an interval exceeding one cycle time. Thus, in principle, the entire growth fraction is labelled. Serial observations in vitro allow kinetic analysis of the rate of proliferation and allow different mitogens to be compared (Fig. 5) . For the fraction of labelled mitoses method, the tissue is pulsed with thymidine and then serial biopsies or samples are taken and autoradiographs are prepared. Inspecting these allows a cohort of labelled cells to be followed through to successive mitoses in the daughter cells. The interval between the successive waves of labelled mitoses represents the time to complete one cell cycle. Schultze [27] has advocated labelling with a second isotope to enhance this in cell cycle transit experiments. For example, ['4C]thymidine given a very short time after the C3H]thyrnidine pulse creates three types of labelled cell: those just exiting S phase are only labelled with [T3H]thymidine, those in mid S phase are labelled with 14C and 3H, and those just entering S phase are only labelled with 14C. The two labels are distinguished because of their different energies: 14C has a greater penetrance through emulsion. An alternative is to use 5-bromodeoxyuridine (BrdU) for the second label (see below).
Biochemical estimation of DNA synthesis. Quantification of 3H-labelled DNA synthesis can be exploited as a surrogate measure of cellular proliferation. In the most rigorous form of the technique, total DNA is extracted and scintillation is used to measure the activity of the isotope in the chemically extracted DNA, yielding the specific activity. More commonly, in, for example, screening for growth factor activity in cell cultures, incorporation of DNA into extracts of cells is compared between different experimental groups, using physical means (e.g. filtration followed by washing) or chemical means (e.g. strong alkali) to sequester nucleoprotein from soluble thymidine (Fig. 6) [28] . This technique has additional pitfalls compared with autoradiography as a measure of proliferation, because the experimental system is more sensitive to the potential extranuclear metabolism of thymidine discussed previously [15] . If whole tissue is being assessed, then, unless specifically separated, the DNA synthesis contributed from stromal cells and migrating or inflammatory cells will also be included. For these reasons, the method should be validated against other measures of proliferation in each experimental setup. Scintillation is also limited to those experiments that can be reduced to cell suspensions or in which the DNA can be extracted.
BrdU. There are modified pyrimidine analogues which can be incorporated into DNA and are detectable without recourse to radioactivity. These include halogenated derivatives of thymidine such as BrdU As BrdU is a potential carcinogen, special precautions are required for the laboratory handling of BrdU, and its use in human tissue is usually limited to studies ex uivo. BrdU can also be used in vitro for cultured cells. Cells are pulsed with BrdU for a short interval before fixing and then denaturing the DNA by brief exposure to acid, which is necessary for anti-BrdU antibody binding. BrdUimmunostained nuclei can be counted to generate a labelling index analogous to thymidine autoradiography. Automated reading of the BrdU incorporation is possible for assays in microtitre plates using a peroxidase-linked antibody to detect anti-BrdU [34].
Other markers of the cell cycle
Other specific events in the cell cycle, either integral to or merely accompanying cell division, can be recorded to quantify cell proliferation. Immediate early genes. The activation of immediate early genes, such as c-jios and c-jun, is a very early event in cell division. In general, however, they are not suitable as markers to assess proliferation: they may be more associated with the priming of cells to undergo proliferation, which may or may not take place; the changes in their expression are very short-lived and, apparently, highly variable with minor changes in experimental conditions. Assessing their expression relies on methods such as Northern blotting or in-situ hybridization, which are complex and may present difficulties in quantifying change [35] .
Polyamine metabolism. The polyamines spermine, spermidine and putrescine are small aliphatic molecules derived from basic amino acids. The relevant pathway is shown in Fig. 7 . Although the precise role of polyamines is unknown, they interact avidly with nucleic acids, proteins and membrane constituents and appear to be important in cell growth, as their regulation is synchronized with the cell cycle. Ornithine decarboxylase (ODC) is one of the key enzymes in the synthesis of polyamines and is very rapidly induced. Polyamine synthesis is stimulated in G1, and also in G2, by an increase in ODC activity [36] . The surge in G1 presumably relates to the preparations for DNA synthesis as ODC activity is less pronounced in mid S phase. In experimental models, enhancement of ODC activity occurs within hours in response to hormones, growth factors or regeneration; for example, ODC activity in rat liver is increased ten-fold within 4 h of partial hepatectomy. The control of ODC activity is complex and appears to be regulated at several levels. Abrahamsen and Morris [37] have shown that, on stimulation, ODC mRNA levels increase in both fibroblasts and T-cells; however, unlike fibroblasts, resting T-cells show elevated ODC transcription. Since there was no difference in stability between the mature ODC mRNA transcripts they concluded that post-transcriptional processing was different in T-cells. Altering rates of intracellular proteolysis of ODC is another potential regulatory mechanism, since the short half-life of ODC means that turnover of the enzyme is rapid. Kopitz et al. [38] have recently shown that the cytosolic enzyme arginyltransferase catalyses the transfer of arginine from tRNA to ODC. The arginylated ODC is rendered particularly susceptible to non-lysosomal degradation, and they suggest this mechanism may be relevant to the regulation of ODC activity.
Assessment of ODC and polyamine levels has been extensively used in tissue extracts as a marker of proliferation. ODC activity is currently measured by trapping the I4CO2 released from labelled ornithine in cell homogenates [39] . This is timeconsuming but the dissociation of ODC activity from changes in its mRNA levels dictates that assessment has to be at the protein or functional level. There has been particular interest in polyamine metabolism in malignant cells [40] , in part reflecting its potential as a chemotherapeutic target since deprivation of polyamines, by inhibition of polyamine synthesis with ornithine analogues such as a-difluoromethylornithine, restrains growth. ODC activity has also been investigated as a means of discriminating premalignant from malignant conditions, especially colorectal neoplasia with elevated levels in neoplastic tissue (reviewed in [41] ).
Celkyclerelated antigens
A number of proteins present in replicating cells are expressed in synchrony with different stages of the cell cycle. Although the function of these molecules is not always known, some have a role in DNA synthesis. Operationally, they can be used to assess the proliferative state of individual cells, since antibodies raised against them will selectively bind to those cells that are replicating. Conversely, antibodies have also been described that recognize an antigen absent in mitosing cells [42] . The proliferation-associated markers include p 105 [43] and DNA polymerase CI [44] among others [45, 461. Two that are frequently cited are proliferating cell nuclear antigen (PCNA) and Ki-67.
PCNA. PCNA is a 36 kDa acidic nuclear protein. It was initially described by Miyachi et al. in 1978 [47] ; they found an autoantibody in the serum of patients with systemic lupus erythematosus that was reactive with the nuclei of proliferating cells (see Fig. 8 ). In 1984, Matthews et al. [48] showed that PCNA was 'cyclin', which is now recognized as a cofactor/auxiliary protein for DNA polymerase 6 [493. This complex forms part of the cellular DNA replication machinery that is essential for cell Fig. 8 . PCNA-stained liver. Hepatocyte proliferation was stimulated by treating rats with a mixture of thyroid hormone, amino acids, glucagon and heparin. Proliferating cells were demonstrated with PCNA. Endogenous peroxidase activity was blocked using methanol and hydrogen peroxide on dewaxed sections of rat liver. Non-rpecific antibody binding was inhibited by horse antiserum. The sections were incubated with anti-PCNA antibody (PC-10) and left at 8°C overnight, washed, incubated with the second antibody (biotinylated horse anti-mouse antibody) and visualized using avidin-conjugated peroxidase and diaminobenzidine. Sections were counterstained with Nuclear Red. Photograph courtesy of Dr M. Carpani. division, although its precise role in promoting cell-cycle progression is still not entirely clear.
PCNA expression changes through the cycle, rising in G1, peaking in S and declining in G2/M. Investigations in cultured cells suggest that two forms of PCNA may be distinguished in different phases of the cell cycle [SO] . The nucleoplasmic form corresponds to the low levels seen in quiescent cells that are still capable of division. This type is soluble, and detergent-extractable, but is not detectable in cells fixed in organic solvents. In contrast, the other form is insoluble, tightly bound to DNA replication sites and is present in organically fixed tissues, where it produces a granular nuclear staining pattern. These staining characteristics may be a manifestation of different functions of PCNA in specific cellular locations.
With the original antibody preparations the antigen proved unstable, tolerated fixation poorly and required fresh tissue specimens. Recently, new monoclonal antibodies that permit more robust handling of tissue have been raised. PClO is a commercially available anti-PCNA antibody that Waseem and Lane [51] and Hall et al. [52] have studied. They found that adequate PCNA staining could be obtained in tissues prepared with a variety of fixatives. In phytohaemagglutinin-stimulated peripheral blood mononuclear cells they showed a parallel rise in PClO staining, BrdU labelling and the S + G2/M fraction, detected by flow cytometry.
Equally, when HeLa cells were induced to stop cycling by exposure to phorbol esters, there was an associated reduction in PClO staining. Fixation times influenced PClO staining with formalin-fixed non-neoplastic tissues in the study of Hall et al. [52] . Material fixed for 48h had reduced staining, and at 72h this was even more pronounced, possibly contributing to some of the observed heterogeneity in immunostaining with anti-PCNA antibodies. Hall et al. [52] also made the interesting observation that areas of seemingly normal tissue adjacent to some tumours showed an increase in PCNA-stained cells. Autocrine or paracrine loops involving growth factors elaborated by the tumour to enhance PCNA expression in the surrounding tissue were postulated.
Ki-67. Ki-67 is an IgG, mouse monoclonal antibody that was raised in 1983 [53] by immunizing mice with a nuclear extract of the Hodgkin's lymphoma cell line L428. Ki-67 recognizes a human cell-cycle-related antigen expressed solely by cycling cells [54] . This is exploited when the Ki-67 antibody is used to assess cell proliferation in human tissue: cells expressing the Ki-67 antigen represent the growth fraction in a population.
The nuclear antigen that the Ki-67 antibody recognizes has recently been identified as a nuclear non-histone protein [55] . Little is understood about its function. Ki-67 antigen first appears in mid G1 and its expression increases progressively throughout the cell cycle to peak in G2/M. The non-cycling cells, GO and early G1, show no staining [56] . There is also evidence of topographical variation in Ki-67 staining within the cycle, as well as qualitative change in stain granularity.
Comparative studies show a correlation between Ki-67 growth fraction, the labelling indices of BrdU [57] and thymidine [SS], as well as flow cytometric measures of proliferation [59] , but this has not been the case universally [60] . Cellular nutrition has been cited as an influence on Ki-67 expression, and this has been invoked to account for some of the observed discrepancies [61] . The interpretation of these observations may be clarified now that the nature of Ki-67 is established.
In clinical laboratories, Ki-67 is popular because it provides a rapid and relatively inexpensive method of measuring dividing cells and it relies on largely familiar techniques [62] . The major practical shortcoming is the lability of the antigen: it does not withstand conventional fixation in formalin or par- afin blocks. Staining after short acetone fixation times is acceptable, as are frozen sections, smears and tissue imprints [62] . Recently, antibodies designated MIB 1 and MIB 3 have been raised to parts of the Ki-67 antigen that detect proliferating cells in formalin-fixed paraffin sections [64] , and they may overcome these limitations (see Fig. 9 ).
The use of antibodies to proliferation-associated antigens raises the issue of quantification and the expression of positive cell counts in stained tissue. In this respect, these methods share many of the constraints discussed in relation to the other morphological assessments. In addition, the immunostaining techniques introduce a further order of potential error with regard to standardization and reproducibility [65] Histone gene expression, which varies with the cell cycle [66] , has also been used to assess proliferation [67] . Studies of mRNA expression in situ correlated with thymidine labelling in mouse liver regeneration [68] . Histone mRNA expression has been used in association with PCNA expression to assess hepatocyte proliferation in alcoholic hepatitis ~691.
Argyrophilic nucleolar organizer regions (AgNORs) (Fig. 10) Nucleolar organizer regions are areas of DNA encoding ribosomal genes that become associated with an argyrophilic protein during transcription. They have been used as an indirect assessment of proliferation in tumours by counting them after silver staining [70] . The aneuploidy of tumours has been proposed to account for the increase in AgNORs in malignant tissue as, in theory, cells with excess genomic material are likely to have more AgNORs. It is more probable that tumour proliferation per se, rather than ploidy, is responsible [71] . Correlation between the AgNOR count and Ki-67 ._ a n .
Y staining [72] has been shown and, also, populations judged to be proliferating using other criteria are relatively richer in cells with more AgNORs. AgNORs are influenced by staining conditions and the length and the type of fixation [73, 741 . The question of how best to quantify AgNORs [75] , and their significance, is unclear.
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Direct methods of assessing proliferation
Counting cells as a means to assess proliferation in uitro has the attraction of simplicity and immediacy but manual counting is laborious. Electronic particle-counters, such as Coulter counters, can be used to count single-cell suspensions. Direct counting becomes inappropriate in mixed cultures and also more problematic in monolayer cultures. For adequate counting, trypsin treatment of monolayers may be required to obtain suspensions and, when counting cells in cultures of non-anchored cells, dead cells must be distinguished from those that are live. Tests such as Trypan Blue exclusion (see Fig.  11 ) are not infallible since dye exclusion is pHdependent, staining of dead cells may be subtle, and the dye also has a strong aftinity for proteins which may be present in the media and compete [76, 771. Fluorescent dyes that enhance the distinction between live and dead cells can overcome some of these drawbacks [78] . Since it may take several days for a cell to lose membrane integrity after a toxic insult which renders it incapable of division, the criteria of membrane integrity as a measure of viability has been questioned [79] . The increase in nuclei in proliferating cultures has limited value for assessment since some cells, particularly tumours, are aneuploid and others, such as primary hepatocytes, increase ploidy on stimulation in culture [SO] .
Indirect assessment
Indirect assessment of proliferation based on cell metabolism and metabolic products unrelated to the cell cycle can be used. Total protein increases with increasing cell numbers, and modified Lowry's methods or the Coomassie Blue method have been used to measure this in culture [Sl] . The latter is particularly suitable for automation, but clearly an increase in cell number is not the only influence on the total protein content which can be stained. In tissue culture in particular, the use of serum supplements or the production of extruded protein matrices may be confounding variables.
Assays based on metabolic activity have been exploited, particularly as they can be automated, and can be rapid and isotope-free. Tetrazolium compounds, such as 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyl tetrazolium bromide (MTT), can be used (Fig. 12) . The method is based on the reduction of the yellow MTT substrate to a purple/blue forma- zan product by the mitochondria1 activity of viable cells, the colour reaction being proportional to cell number [83, 841 . In cell suspension this technique is particularly simple, and a number of authors have validated this as a measure of proliferation. Others have found discrepancies between MTT and direct cell counts; factors such as culture pH and cell density may be confounding variables [85, 861.
A variety of cell products have been used for measuring proliferation. The lysosomal enzyme Nacetyl-P-d-glucosaminidase can be assayed using a spectrophotometric method and a p-nitrophenolderivatized substrate; activity is proportional to the cell number, although different standard curves are required for each cell type [87] . Lactate dehydrogenase in hepatic lysates is proportional to cell numbers, and this has been used to quantify hepato- Mitochondria1 enzymes convert the yellow MTT to a coloured formazan product, which is then dissolved in acid isopropanol. The absorbance is proportional to cell numbers.
cytes [88, 891 . The fact that leakage of the same enzyme into culture media is a common measure of cell damage in cytotoxicity assays demonstrates that factors such as cell viability may confound this measurement [90] .
COMBINED TECHNIQUES
Flow cytometry
Cell and tissue kinetics can be investigated with flow cytometry. It is a very powerful tool that draws on the techniques that have been considered: detecting cells in DNA synthesis and measuring immunocytochemical markers. These can be combined with cell counting, measuring ploidy and the DNA content in cells.
The flow cytometer generates a stream of particles, either nuclei or cells, that traverse the path of a laser light. Interaction between the light beam and the cells results in the excitation of fluorochromes that are either conjugated to antibodies bound to the cell surface or integrated into the DNA. The light is also made to scatter by the physical characteristics of the cells. The forward angle scatter at 10" is related to cell volume, and that at 90" correlates with refraction from internal structures. Light is directed to photomultiplier detectors that translate the signal to an electrical form that can then be processed.
There are several ways that a flow cytometer can be configured to investigate cell proliferation (reviewed by Larsen [Sl] ). Apart from counting, the simplest strategy is to measure cellular DNA content, since quiescent cells and those in the presynthetic phases of the cycle (G0/1) have half the DNA of the cells in G2/M, whereas those in S have an intermediate value. Populations that are proliferating will be richer in the cells in S and G2/M than those not proliferating. This can be used as a crude proliferative index. A variety of fluorochromes can stain DNA stoichiometrically to render the DNA fluorescent when the laser interrogates the cell. This allows cellular DNA content to be measured, which is displayed as a DNA histogram once it is anal ysed.
Another strategy is to detect BrdU incorporated into DNA either by monoclonal antibodies or by the interference (through enhancement or quenching) it produces with the staining of certain DNA fluorochromes [92] . Dolbeare et al. [93] have described another technique measuring total DNA and BrdU-linked neosynthetic DNA to detect S-phase cells.
Flow cytometry can examine the distribution of cell proliferation markers if antibodies are linked to fluorochromes [94] . These analyses can be combined with measures of DNA [95] .
The statistical power of flow cytometry is its advantage as 1@100 000 cells in a population are examined in an accurate and repeatable way. The practical drawback is the absolute requirement for suspensions of individual cells, although methods are available that can use paraffin-embedded tissue [96] . The cost and technical expertise required to operate the flow cytometer and interpret its data are also disadvantages.
CONCLUSIONS
In many areas of biomedical research, assessing cell proliferation is a basic requirement. There are a variety of approaches that range from simple methods, such as direct counting, through to involved, expensive and time-consuming assays. Clearly, each technique has its advantages and disadvantages, and the method chosen will depend on the problem to be addressed. We hope that this overview of current approaches will have introduced the principles underlying the important methods, and provided a perspective on the limitations to anyone contemplating how to assess proliferation.
